Cargando…
Extensive molecular screening for hereditary non-polyposis colorectal cancer
The genetic abnormalities underlying hereditary non-polyposis colorectal cancer (HNPCC) are germline mutations in one of five DNA mismatch repair genes or in the TGFβRII gene. The aim of our study was to evaluate the significance of simple tests performed on tumours to select appropriate candidates...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374417/ https://www.ncbi.nlm.nih.gov/pubmed/10732761 http://dx.doi.org/10.1054/bjoc.1999.1014 |
_version_ | 1782154448562290688 |
---|---|
author | Dieumegard, B Grandjouan, S Sabourin, J-C Bihan, M-L Le Lefrère, I Bellefqih Pignon, J-P Rougier, P Lasser, P Bénard, J Couturier, D Bressac-de Paillerets, B |
author_facet | Dieumegard, B Grandjouan, S Sabourin, J-C Bihan, M-L Le Lefrère, I Bellefqih Pignon, J-P Rougier, P Lasser, P Bénard, J Couturier, D Bressac-de Paillerets, B |
author_sort | Dieumegard, B |
collection | PubMed |
description | The genetic abnormalities underlying hereditary non-polyposis colorectal cancer (HNPCC) are germline mutations in one of five DNA mismatch repair genes or in the TGFβRII gene. The aim of our study was to evaluate the significance of simple tests performed on tumours to select appropriate candidates for germline mutational analysis. We studied three groups of patients, HNPCC kindreds fulfilling the International Collaborative Group (ICG) criteria (n = 10), families in which at least one of the criteria was not satisfied (n = 7) and sporadic colorectal cancer (CRC) diagnosed before the age of 50 (n = 17). We searched for microsatellite instability (MSI), presence of hMSH2 and hMLH1 germline mutations, expression of hMSH2, hMLH1 and p53 proteins in tumoural tissue samples by immunostaining. Fifteen out of 17 (88%) of HNPCC and incomplete HNPCC cases were MSI and eight pathogenic germline mutations in hMSH2 or hMLH1 were detected in these two groups (53%). All the 17 early-onset sporadic cases were MSS and no germline mutations were detected among the seven investigated cases. Thirteen out of 15 (81%) familial cases were MSI and p53 protein-negative, whereas 13/14 (93%) sporadic cases were MSS and strongly p53 protein-positive. This extensive molecular investigation shows that simple tests such as MS study combined with hMSH2 and hMLH1 protein immunostaining performed on tumoural tissues may provide valuable information to distinguish between familial, and probably hereditary, and sporadic CRC cases. © 2000 Cancer Research Campaign |
format | Text |
id | pubmed-2374417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23744172009-09-10 Extensive molecular screening for hereditary non-polyposis colorectal cancer Dieumegard, B Grandjouan, S Sabourin, J-C Bihan, M-L Le Lefrère, I Bellefqih Pignon, J-P Rougier, P Lasser, P Bénard, J Couturier, D Bressac-de Paillerets, B Br J Cancer Regular Article The genetic abnormalities underlying hereditary non-polyposis colorectal cancer (HNPCC) are germline mutations in one of five DNA mismatch repair genes or in the TGFβRII gene. The aim of our study was to evaluate the significance of simple tests performed on tumours to select appropriate candidates for germline mutational analysis. We studied three groups of patients, HNPCC kindreds fulfilling the International Collaborative Group (ICG) criteria (n = 10), families in which at least one of the criteria was not satisfied (n = 7) and sporadic colorectal cancer (CRC) diagnosed before the age of 50 (n = 17). We searched for microsatellite instability (MSI), presence of hMSH2 and hMLH1 germline mutations, expression of hMSH2, hMLH1 and p53 proteins in tumoural tissue samples by immunostaining. Fifteen out of 17 (88%) of HNPCC and incomplete HNPCC cases were MSI and eight pathogenic germline mutations in hMSH2 or hMLH1 were detected in these two groups (53%). All the 17 early-onset sporadic cases were MSS and no germline mutations were detected among the seven investigated cases. Thirteen out of 15 (81%) familial cases were MSI and p53 protein-negative, whereas 13/14 (93%) sporadic cases were MSS and strongly p53 protein-positive. This extensive molecular investigation shows that simple tests such as MS study combined with hMSH2 and hMLH1 protein immunostaining performed on tumoural tissues may provide valuable information to distinguish between familial, and probably hereditary, and sporadic CRC cases. © 2000 Cancer Research Campaign Nature Publishing Group 2000-02 /pmc/articles/PMC2374417/ /pubmed/10732761 http://dx.doi.org/10.1054/bjoc.1999.1014 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Dieumegard, B Grandjouan, S Sabourin, J-C Bihan, M-L Le Lefrère, I Bellefqih Pignon, J-P Rougier, P Lasser, P Bénard, J Couturier, D Bressac-de Paillerets, B Extensive molecular screening for hereditary non-polyposis colorectal cancer |
title | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
title_full | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
title_fullStr | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
title_full_unstemmed | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
title_short | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
title_sort | extensive molecular screening for hereditary non-polyposis colorectal cancer |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374417/ https://www.ncbi.nlm.nih.gov/pubmed/10732761 http://dx.doi.org/10.1054/bjoc.1999.1014 |
work_keys_str_mv | AT dieumegardb extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT grandjouans extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT sabourinjc extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT bihanmlle extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT lefrerei extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT bellefqih extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT pignonjp extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT rougierp extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT lasserp extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT benardj extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT couturierd extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer AT bressacdepailleretsb extensivemolecularscreeningforhereditarynonpolyposiscolorectalcancer |